Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vericel Corporation (NQ: VCEL ) 44.91 -0.16 (-0.36%) Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Vericel Corporation < Previous 1 2 Next > Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024 June 11, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 May 22, 2024 From Vericel Corporation Via GlobeNewswire Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance May 08, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024 April 24, 2024 From Vericel Corporation Via GlobeNewswire Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance February 29, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 February 27, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024 February 15, 2024 From Vericel Corporation Via GlobeNewswire 5 medical stocks growing earnings by triple digits February 06, 2024 There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning Via MarketBeat Topics Economy Exposures Economy Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024 February 05, 2024 From Vericel Corporation Via GlobeNewswire Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session January 23, 2024 Via Investor Brand Network Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results January 09, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 January 03, 2024 From Vericel Corporation Via GlobeNewswire Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance November 08, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Present at the Stephens Annual Investment Conference November 07, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023 October 25, 2023 From Vericel Corporation Via GlobeNewswire Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid September 28, 2023 From Vericel Corporation Via GlobeNewswire Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults September 20, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Present at the Morgan Stanley Global Healthcare Conference September 06, 2023 From Vericel Corporation Via GlobeNewswire Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance August 02, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023 July 20, 2023 From Vericel Corporation Via GlobeNewswire Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session May 23, 2023 Via Investor Brand Network Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance May 10, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023 April 26, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023 February 28, 2023 From Vericel Corporation Via GlobeNewswire Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance February 23, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023 February 09, 2023 From Vericel Corporation Via GlobeNewswire Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program January 10, 2023 From Vericel Corporation Via GlobeNewswire Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 January 04, 2023 From Vericel Corporation Via GlobeNewswire MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults December 29, 2022 From MediWound Ltd. Via GlobeNewswire Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults December 29, 2022 From Vericel Corporation Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.